Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis
Beijing Friendship Hospital
Beijing Friendship Hospital
NGM Biopharmaceuticals, Inc
IRCCS Ospedale San Raffaele
Association Francaise pour la Recherche Thermale
Universitair Ziekenhuis Brussel
SpotitEarly
University Hospital, Ghent
Uppsala University
Novosanis NV
Lebanese University
Kineta Inc.
Namida Lab
Université Sorbonne Paris Nord
MiRXES Pte Ltd
Impact Therapeutics, Inc.
Blue Note Therapeutics
Boston VA Research Institute, Inc.
Imperial College London
Hospital de Clinicas de Porto Alegre
Assistance Publique - Hôpitaux de Paris
Weprom
Instituto de Investigacion Sanitaria La Fe
Jerome Canady Research Institute for Advanced Biological & Technological Sciences
Hamilton Health Sciences Corporation
Charite University, Berlin, Germany
SpeciCare
Instituto Portugues de Oncologia, Francisco Gentil, Porto
Chinese University of Hong Kong
Samyang Biopharmaceuticals Corporation
Instituto do Cancer do Estado de São Paulo
The University of The West Indies
CytoMed Therapeutics Pte Ltd
Royal Marsden NHS Foundation Trust
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
KU Leuven
Placon Therapeutics
Wuxi No. 4 People's Hospital
Optimata Ltd.
National University Hospital, Singapore
The Cooper Health System
AHS Cancer Control Alberta
Chinese PLA General Hospital
Comprehensive Cancer Centers of Nevada
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Meir Medical Center
Arizona Oncology Services
Tel-Aviv Sourasky Medical Center